With Merck’s COVID Antiviral Announcement, Can the Pharma Pipeline Build Treatment Momentum?

 

At the start of the month, pharmaceutical company Merck dropped big news: It has developed a COVID antiviral drug that would cut hospitalization and mortality risks by 50%. In the drug’s study, patients taking the placebo pill saw 14% hospitalization rate and eight deaths, while the trial group with Merck’s drug had only 7% hospitalized and zero deaths.

This appears to be just the tip of the iceberg; Kaiser Health News reports at least three COVID antiviral candidates, including Merck’s, going through late-stage clinical trials, meaning a variety of COVID drugs could be on patient’s prescriptions here soon. What’ll be some of the positive domino effects to come from approval of COVID antivirals, not only on the pharmaceutical production pipeline, but on the general population’s health? Ira Leiderman, managing director of the healthcare practice at Cassel Salpeter & Co., gave MarketScale his take on the coming treatments.

Follow us on social media for the latest updates in B2B!

Image

Latest

Texas
Policy, Patients, and the Future of Healthcare: How Texas Plans to Fix a Strained System
May 4, 2026

The U.S. healthcare system is under real strain—and it’s something both patients and physicians are feeling in everyday care. In Texas, those pressures are even more visible, where rapid population growth, rural access challenges, and regulatory complexity are making it harder for patients to get timely care and for doctors to focus on medicine…

Read More
adaptive learning
Scaling Career-Ready Skills: How Adaptive Learning and Generative AI Are Transforming Higher Education
May 4, 2026

Skills-based learning has moved from buzzword to mandate as colleges face mounting pressure to connect credentials, employability, and measurable learner outcomes. Employers are increasingly using skills-based hiring practices, and NACE’s Job Outlook 2026 notes that students need to demonstrate concrete examples of skills in action during hiring processes. At the same time, higher education…

Read More
Gen Alpha
A Gen Alpha Take on Experiential Retail: What Works, What Doesn’t, and What’s Missing
May 4, 2026

Gen Alpha is no longer a future consumer segment—they are already shaping how retail and entertainment experiences are designed today. Research from MG2 shows that a whopping 70% of Gen Alpha influence what adults in their lives purchase, reshaping brand decisions faster than many companies are prepared for. As experiential retail continues to evolve—with…

Read More
TGR Foundation
Tiger Woods’ TGR Foundation Is Reimagining Education Through Learning Labs and Hands-On STEM Experiences
May 4, 2026

Education systems around the world are under pressure to evolve faster than ever, especially for underserved communities. In the U.S. alone, millions of students in low-income households still lack access to STEM resources and career pathways—fueling a widening opportunity gap. For more than 30 years, the TGR Foundation, founded by Tiger Woods, has worked…

Read More